MUX McEwen Mining | $7.45
+0.8% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $18.00 -> $15.50 | Low | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 5/9/2025 |
ALEC Alector | $1.18
+13.0% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $7.00 -> $10.00 | High | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 5/9/2025 |
PRTA Prothena | $7.43
+4.6% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $48.00 -> $30.00 | Low | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 5/9/2025 |
PEPG PepGen | $1.50
-2.6% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $14.00 | High | View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 5/9/2025 |
GHRS GH Research | $10.42
-3.5% | 5/9/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/9/2025 |
AMLX Amylyx Pharmaceuticals | $4.61
+0.7% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $12.00 -> $16.00 | Low | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 5/9/2025 |
DYN Dyne Therapeutics | $11.44
+1.2% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $46.00 -> $38.00 | Medium | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 5/9/2025 |
VSTM Verastem | $7.17
+3.3% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $10.00 -> $14.00 | Medium | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 5/9/2025 |
CRDF Cardiff Oncology | $2.66
+1.1% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $17.00 -> $18.00 | Low | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 5/9/2025 |
AG First Majestic Silver | $5.90
+7.1% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.00 -> $11.50 | High | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 5/9/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
UAMY United States Antimony | $3.28
-6.8% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $2.60 -> $4.50 | High | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 5/9/2025 |
UUUU Energy Fuels | $4.76
| 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $10.75 -> $10.00 | N/A | View details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 5/9/2025 |
HUT Hut 8 | $13.89
-2.0% | 5/9/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 5/9/2025 |
ALXO ALX Oncology | $0.42
-8.2% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $2.00 | High | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 5/9/2025 |
VOR Vor Biopharma | $0.15
-5.4% | 5/9/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Neutral | | High | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 5/9/2025 |
IOVA Iovance Biotherapeutics | $1.75
-44.8% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $32.00 -> $20.00 | N/A | View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/9/2025 |
FEMY Femasys | $1.06
-7.8% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $15.00 -> $12.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 5/9/2025 |
SAND Sandstorm Gold | $8.81
+3.3% | 5/8/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.50 -> $11.75 | Medium | View details for HC Wainwright rating of Sandstorm Gold (NYSE:SAND) on 5/8/2025 |
LENZ LENZ Therapeutics | $26.34
+1.8% | 5/8/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of LENZ Therapeutics (NASDAQ:LENZ) on 5/8/2025 |
KROS Keros Therapeutics | $13.65
-2.6% | 5/8/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $40.00 -> $25.00 | Medium | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 5/8/2025 |
ITRM Iterum Therapeutics | $1.02
-2.9% | 5/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $9.00 | High | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 5/8/2025 |
KRRO Korro Bio | $15.56
+1.0% | 5/8/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $115.00 -> $100.00 | High | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 5/8/2025 |
CIFR Cipher Mining | $2.98
-4.5% | 5/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | High | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 5/6/2025 |
DNLI Denali Therapeutics | $14.39
-0.3% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $80.00 -> $32.00 | High | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 5/7/2025 |
VNDA Vanda Pharmaceuticals | $3.96
-6.2% | 5/7/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 5/7/2025 |
SRPT Sarepta Therapeutics | $36.27
-0.7% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $75.00 -> $40.00 | High | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/7/2025 |
CRBP Corbus Pharmaceuticals | $6.45
-3.0% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $50.00 -> $40.00 | High | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/7/2025 |
AXSM Axsome Therapeutics | $107.76
-1.0% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $200.00 -> $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/7/2025 |
TCRX TScan Therapeutics | $1.29
-6.9% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $15.00 -> $10.00 | Low | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 5/7/2025 |
PSNL Personalis | $5.04
-2.3% | 5/7/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $9.00 | High | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 5/7/2025 |
KRYS Krystal Biotech | $132.23
-3.6% | 5/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $240.00 -> $240.00 | High | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/6/2025 |
ALKS Alkermes | $30.15
-0.8% | 5/2/2025 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 5/2/2025 |
IBRX ImmunityBio | $2.07
-1.0% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | | High | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 5/5/2025 |
EKSO Ekso Bionics | $0.42
+1.6% | 5/6/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $9.00 -> $4.00 | High | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 5/6/2025 |
CORT Corcept Therapeutics | $70.23
-1.6% | 5/6/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $150.00 -> $145.00 | High | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 5/6/2025 |
CLDX Celldex Therapeutics | $18.33
-6.1% | 5/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 5/6/2025 |
BMEA Biomea Fusion | $1.63
-7.0% | 5/6/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $18.00 | High | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 5/6/2025 |
BCRX BioCryst Pharmaceuticals | $9.98
+0.6% | 5/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/6/2025 |
VERA Vera Therapeutics | $21.77
-1.2% | 5/5/2025 | Initiated by | HC Wainwright | Analyst Arthur He | Buy | $75.00 | Low | View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 5/5/2025 |
NPKI NPK International | $8.41
+4.3% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of NPK International (NYSE:NPKI) on 5/5/2025 |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
INTZ Intrusion | $1.43
-5.3% | 5/5/2025 | Target Raised by | HC Wainwright | Analyst Scott Buck | Neutral -> Neutral | $1.00 -> $1.50 | Medium | View details for HC Wainwright rating of Intrusion (NASDAQ:INTZ) on 5/5/2025 |
PRLD Prelude Therapeutics | $0.78
-4.5% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 5/5/2025 |
ORIC ORIC Pharmaceuticals | $5.08
-4.5% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/5/2025 |
RGEN Repligen | $123.24
-3.6% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $180.00 -> $180.00 | Low | View details for HC Wainwright rating of Repligen (NASDAQ:RGEN) on 5/5/2025 |
TRML Tourmaline Bio | $15.09
-4.1% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 5/5/2025 |
OKYO OKYO Pharma | $1.45
-2.0% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 5/5/2025 |
DBVT DBV Technologies | $9.83
-0.1% | 5/5/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $7.00 -> $16.00 | High | View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 5/5/2025 |
CDNA CareDx | $15.42
+0.2% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Neutral -> Neutral | $25.00 -> $25.00 | Medium | View details for HC Wainwright rating of CareDx (NASDAQ:CDNA) on 5/5/2025 |
UTHR United Therapeutics | $301.42
-2.1% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $425.00 -> $425.00 | Low | View details for HC Wainwright rating of United Therapeutics (NASDAQ:UTHR) on 5/5/2025 |
ARVN Arvinas | $6.61
-2.9% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $24.00 | High | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 5/2/2025 |
BIIB Biogen | $118.20
-0.2% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $241.00 -> $187.00 | Medium | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 5/2/2025 |
XFOR X4 Pharmaceuticals | $3.36
+2.1% | 5/2/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $1.50 -> $7.00 | Medium | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 5/2/2025 |
PHAT Phathom Pharmaceuticals | $3.14
+37.1% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $28.00 -> $20.00 | High | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 5/2/2025 |
BLCO Bausch + Lomb | $11.23
-2.3% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $20.00 -> $15.00 | Medium | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 5/2/2025 |
BPMC Blueprint Medicines | $97.74
-1.0% | 5/2/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $135.00 -> $135.00 | High | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 5/2/2025 |
IONS Ionis Pharmaceuticals | $32.26
-1.5% | 5/1/2025 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $50.00 | Low | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/1/2025 |
ACIU AC Immune | $1.67
+0.6% | 5/1/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 5/1/2025 |
VGZ Vista Gold | $1.03
+1.0% | 5/1/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.75 -> $2.75 | High | View details for HC Wainwright rating of Vista Gold (NYSE:VGZ) on 5/1/2025 |
PRAX Praxis Precision Medicines | $38.35
+0.8% | 5/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $105.00 -> $105.00 | Medium | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/1/2025 |
IMUX Immunic | $1.01
-1.0% | 5/1/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 5/1/2025 |
SWTX SpringWorks Therapeutics | $46.26
+0.1% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Neutral | $74.00 -> $47.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 4/30/2025 |
JOBY Joby Aviation | $6.78
+2.0% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 4/30/2025 |
AEYE AudioEye | $12.51
+4.9% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/30/2025 |
ALMS Alumis | $5.03
-5.5% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $14.00 -> $14.00 | Medium | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 4/30/2025 |
FHTX Foghorn Therapeutics | $4.20
-7.3% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/30/2025 |
ERAS Erasca | $1.39
| 4/30/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $6.00 -> $6.00 | Low | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 4/30/2025 |
PVLA Palvella Therapeutics | $22.77
-1.2% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 4/30/2025 |
LFMD LifeMD | $8.26
+1.2% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 4/30/2025 |
ZYXI Zynex | $2.08
-1.9% | 4/30/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $8.00 | High | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 4/30/2025 |
NVCT Nuvectis Pharma | $8.99
-2.5% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $11.00 -> $15.00 | Low | View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 4/30/2025 |
AGEN Agenus | $2.93
-3.6% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 4/30/2025 |
ABEO Abeona Therapeutics | $5.27
-4.0% | 4/30/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $15.00 -> $20.00 | High | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/30/2025 |
VRNA Verona Pharma | $63.36
-4.4% | 4/30/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $75.00 -> $85.00 | Low | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 4/30/2025 |
CECO CECO Environmental | $24.95
-2.2% | 4/30/2025 | Upgraded by | HC Wainwright | Analyst A. Dayal | Neutral -> Buy | $33.00 | High | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 4/30/2025 |
DRTS Alpha Tau Medical | $2.92
| 4/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 4/29/2025 |
NB NioCorp Developments | $2.43
-2.0% | 4/29/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.25 -> $4.25 | High | View details for HC Wainwright rating of NioCorp Developments (NASDAQ:NB) on 4/29/2025 |
RZLV Rezolve AI | $2.02
-12.2% | 4/29/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Rezolve AI (NASDAQ:RZLV) on 4/29/2025 |
CHRS Coherus BioSciences | $0.97
-2.7% | 4/29/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 4/29/2025 |
MSTR Strategy | $415.93
+0.4% | 4/29/2025 | Initiated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $480.00 -> $480.00 | Medium | View details for HC Wainwright rating of Strategy (NASDAQ:MSTR) on 4/29/2025 |
STRO Sutro Biopharma | $0.87
-9.1% | 4/29/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Neutral -> Neutral | $2.00 -> $2.00 | Medium | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 4/29/2025 |
EDIT Editas Medicine | $1.45
+4.3% | 4/28/2025 | Upgraded by | HC Wainwright | Analyst M. Kapoor | Strong-Buy | $3.00 | Low | View details for HC Wainwright rating of Editas Medicine (NASDAQ:EDIT) on 4/28/2025 |
ATNM Actinium Pharmaceuticals | $1.48
+3.5% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 4/28/2025 |
KURA Kura Oncology | $5.77
-3.8% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 4/28/2025 |
KRYS Krystal Biotech | $132.23
-3.6% | 4/28/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $221.00 -> $240.00 | Medium | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 4/28/2025 |
IBRX ImmunityBio | $2.07
-1.0% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 4/28/2025 |
RZLT Rezolute | $3.69
-0.8% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $14.00 -> $14.00 | Low | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 4/28/2025 |
CGON CG Oncology | $23.74
-1.6% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 4/28/2025 |
TARA Protara Therapeutics | $3.24
-3.9% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 4/28/2025 |
URGN UroGen Pharma | $10.35
-3.0% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $55.00 -> $55.00 | High | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/28/2025 |
OLMA Olema Pharmaceuticals | $4.60
-1.5% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Low | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 4/28/2025 |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
EDIT Editas Medicine | $1.45
+4.3% | 4/28/2025 | Initiated by | HC Wainwright | Analyst Mitchell Kapoor | Buy | $3.00 | Low | View details for HC Wainwright rating of Editas Medicine (NASDAQ:EDIT) on 4/28/2025 |
SMMT Summit Therapeutics | $23.96
-2.8% | 4/28/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $44.00 | High | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 4/28/2025 |
CRBU Caribou Biosciences | $0.77
-2.0% | 4/28/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $9.00 -> $3.00 | High | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 4/28/2025 |
BCPC Balchem | $163.60
-1.0% | 4/28/2025 | Target Set by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $190.00 -> $180.00 | Medium | View details for HC Wainwright rating of Balchem (NASDAQ:BCPC) on 4/28/2025 |
VYNE VYNE Therapeutics | $1.30
| 4/25/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.75 -> $4.50 | High | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 4/25/2025 |
LYTS LSI Industries | $15.95
-0.9% | 4/25/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 4/25/2025 |
LGO Largo | $1.49
+3.5% | 4/25/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.90 -> $3.90 | Low | View details for HC Wainwright rating of Largo (NYSE:LGO) on 4/25/2025 |
ESPR Esperion Therapeutics | $0.80
-10.6% | 4/25/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 4/25/2025 |
TNYA Tenaya Therapeutics | $0.41
-6.1% | 4/25/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 4/25/2025 |
HALO Halozyme Therapeutics | $65.86
-2.8% | 4/25/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $72.00 -> $72.00 | Medium | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/25/2025 |
OBIO Orchestra BioMed | $2.65
-7.7% | 4/23/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Low | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 4/23/2025 |
FPAY FlexShopper | $1.37
+4.6% | 4/24/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 4/24/2025 |
MARA MARA | $15.74
+10.1% | 4/24/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $28.00 -> $28.00 | Low | View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 4/24/2025 |
MAG MAG Silver | $16.92
+6.2% | 4/24/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/24/2025 |
VKTX Viking Therapeutics | $27.61
-0.9% | 4/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 4/24/2025 |
IPHA Innate Pharma | $2.44
+2.5% | 4/24/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $11.50 -> $11.00 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 4/24/2025 |
SANA Sana Biotechnology | $1.81
| 4/24/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 4/24/2025 |
UBX Unity Biotechnology | $0.91
+0.5% | 4/23/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 4/23/2025 |
VRDN Viridian Therapeutics | $12.54
-1.9% | 4/23/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $34.00 -> $34.00 | Low | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 4/23/2025 |
ITRG Integra Resources | $1.72
-0.6% | 4/23/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.75 -> $2.75 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 4/23/2025 |
OKLO Oklo | $28.09
+4.2% | 4/23/2025 | Initiated by | HC Wainwright | Analyst Sameer Joshi | Buy | $55.00 | High | View details for HC Wainwright rating of Oklo (NYSE:OKLO) on 4/23/2025 |
WKEY WISeKey International | $4.48
-3.2% | 4/23/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of WISeKey International (NASDAQ:WKEY) on 4/23/2025 |
WKSP Worksport | $2.90
+2.1% | 4/23/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $11.50 -> $11.50 | High | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 4/23/2025 |
BCTX BriaCell Therapeutics | $3.11
-2.2% | 4/22/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $32.00 -> $32.00 | High | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 4/22/2025 |
UROY Uranium Royalty | $1.93
+0.5% | 4/22/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.70 -> $4.50 | Medium | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 4/22/2025 |
GPCR Structure Therapeutics | $25.56
-4.7% | 4/22/2025 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $80.00 -> $80.00 | Medium | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 4/22/2025 |
INSM Insmed | $65.08
-0.8% | 4/22/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $90.00 -> $90.00 | High | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 4/22/2025 |
NBIX Neurocrine Biosciences | $115.71
-1.5% | 4/22/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $185.00 -> $168.00 | Low | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/22/2025 |
ALMS Alumis | $5.03
-5.5% | 4/22/2025 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $15.00 -> $14.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 4/22/2025 |
CYTK Cytokinetics | $31.69
-2.4% | 4/21/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 4/21/2025 |
CMPX Compass Therapeutics | $1.82
+2.2% | 4/21/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $24.00 -> $24.00 | Medium | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/21/2025 |
ROIV Roivant Sciences | $10.65
-3.4% | 4/21/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/21/2025 |
QURE uniQure | $12.78
+4.3% | 4/21/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 4/21/2025 |
GLSI Greenwich LifeSciences | $9.43
-2.4% | 4/21/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $38.00 -> $39.00 | Low | View details for HC Wainwright rating of Greenwich LifeSciences (NASDAQ:GLSI) on 4/21/2025 |
BTBT Bit Digital | $2.08
| 4/21/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 4/21/2025 |
FURY Fury Gold Mines | $0.38
+1.4% | 4/21/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.10 -> $1.20 | N/A | View details for HC Wainwright rating of Fury Gold Mines (NYSEAMERICAN:FURY) on 4/21/2025 |
VKTX Viking Therapeutics | $27.61
-0.9% | 4/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 4/17/2025 |
WYY WidePoint | $5.47
+9.0% | 4/17/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of WidePoint (NYSEAMERICAN:WYY) on 4/17/2025 |
CLIR ClearSign Technologies | $0.54
+2.7% | 4/17/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $6.00 -> $2.00 | Low | View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 4/17/2025 |
ASM Avino Silver & Gold Mines | $2.49
+70.2% | 4/17/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.20 -> $2.20 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/17/2025 |
ASM Avino Silver & Gold Mines | $2.59
+7.0% | 4/17/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.20 -> $2.20 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/17/2025 |
OCS Oculis | $18.49
-1.1% | 4/17/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $29.00 -> $32.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 4/17/2025 |
GOVX GeoVax Labs | $0.93
-4.4% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of GeoVax Labs (NASDAQ:GOVX) on 4/16/2025 |
CGEM Cullinan Therapeutics | $7.59
-2.3% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $33.00 -> $33.00 | Low | View details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 4/16/2025 |
CRDL Cardiol Therapeutics | $1.15
+0.9% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/16/2025 |
PPSI Pioneer Power Solutions | $2.43
+1.3% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Pioneer Power Solutions (NASDAQ:PPSI) on 4/16/2025 |
RZLV Rezolve AI | $2.02
-12.2% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $4.00 -> $4.00 | Medium | View details for HC Wainwright rating of Rezolve AI (NASDAQ:RZLV) on 4/16/2025 |
IBRX ImmunityBio | $2.07
-1.0% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 4/16/2025 |
ADVM Adverum Biotechnologies | $2.80
-10.3% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/16/2025 |
LENZ LENZ Therapeutics | $26.34
+1.8% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $38.00 -> $38.00 | Low | View details for HC Wainwright rating of LENZ Therapeutics (NASDAQ:LENZ) on 4/16/2025 |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
LYEL Lyell Immunopharma | $0.40
-6.5% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $1.00 -> $1.00 | Medium | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 4/16/2025 |
SRPT Sarepta Therapeutics | $36.27
-0.7% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/16/2025 |
LEGN Legend Biotech | $31.58
-1.4% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/16/2025 |
VANI Vivani Medical | $1.04
+1.5% | 4/16/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 4/16/2025 |
CYTK Cytokinetics | $31.69
-2.4% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | Medium | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 4/15/2025 |
URG Ur-Energy | $0.71
+2.4% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.70 -> $2.70 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 4/15/2025 |
GLDG GoldMining | $0.81
+2.1% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.25 -> $3.25 | N/A | View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 4/15/2025 |
TOMZ TOMI Environmental Solutions | $0.86
+1.9% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.50 -> $3.50 | Low | View details for HC Wainwright rating of TOMI Environmental Solutions (NASDAQ:TOMZ) on 4/15/2025 |
APLD Applied Digital | $5.39
-2.0% | 4/15/2025 | Target Lowered by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $12.00 -> $7.00 | High | View details for HC Wainwright rating of Applied Digital (NASDAQ:APLD) on 4/15/2025 |
VALN Valneva | $6.47
+1.4% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 4/15/2025 |
SLNO Soleno Therapeutics | $76.77
+0.7% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $100.00 -> $100.00 | Medium | View details for HC Wainwright rating of Soleno Therapeutics (NASDAQ:SLNO) on 4/15/2025 |
BBIO BridgeBio Pharma | $34.17
-2.0% | 4/15/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $49.00 -> $53.00 | Medium | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 4/15/2025 |
IMUX Immunic | $1.01
-1.0% | 4/15/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 4/15/2025 |
VERV Verve Therapeutics | $4.23
-5.6% | 4/14/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $25.00 | High | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 4/14/2025 |
FLD FTAC Emerald Acquisition | $3.99
-3.6% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of FTAC Emerald Acquisition (NASDAQ:FLD) on 4/14/2025 |
ATEC Alphatec | $12.22
-4.1% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Alphatec (NASDAQ:ATEC) on 4/14/2025 |
TNGX Tango Therapeutics | $1.12
+1.8% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 4/14/2025 |
PYPD PolyPid | $2.77
+1.8% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 4/14/2025 |
IPA ImmunoPrecise Antibodies | $0.45
-1.9% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 4/11/2025 |
BTCM BIT Mining | $1.84
+5.7% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | Low | View details for HC Wainwright rating of BIT Mining (NYSE:BTCM) on 4/11/2025 |
RR Richtech Robotics | $1.97
-3.9% | 4/11/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $3.50 | High | View details for HC Wainwright rating of Richtech Robotics (NASDAQ:RR) on 4/11/2025 |
WRN Western Copper & Gold | $1.16
+3.6% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.25 -> $4.25 | High | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 4/11/2025 |
CADL Candel Therapeutics | $4.80
+0.8% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 4/11/2025 |
UNCY Unicycive Therapeutics | $0.55
-11.6% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | Medium | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/11/2025 |
PTGX Protagonist Therapeutics | $43.04
-2.0% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $80.00 -> $80.00 | Low | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 4/10/2025 |
ARCT Arcturus Therapeutics | $10.98
-3.5% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 4/10/2025 |
INZY Inozyme Pharma | $1.16
-6.5% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 4/10/2025 |
EXK Endeavour Silver | $3.57
+6.3% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.25 -> $7.25 | Medium | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 4/10/2025 |
EOLS Evolus | $9.80
-2.9% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 4/10/2025 |
TPST Tempest Therapeutics | $6.49
-5.3% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 4/10/2025 |
MBOT Microbot Medical | $2.52
-1.6% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 4/10/2025 |
VALN Valneva | $6.47
+1.4% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | High | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 4/9/2025 |
FTCI FTC Solar | $3.37
+2.1% | 4/8/2025 | Target Raised by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $1.50 -> $5.00 | High | View details for HC Wainwright rating of FTC Solar (NASDAQ:FTCI) on 4/8/2025 |
ARGX argenx | $549.65
-3.4% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $720.00 -> $720.00 | High | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 4/8/2025 |
WPRT Westport Fuel Systems | $2.76
-1.8% | 4/9/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $22.00 -> $7.00 | High | View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 4/9/2025 |
VTVT vTv Therapeutics | $20.80
+3.6% | 4/9/2025 | Initiated by | HC Wainwright | Analyst Emily Bodnar | Buy | $36.00 | Medium | View details for HC Wainwright rating of vTv Therapeutics (NASDAQ:VTVT) on 4/9/2025 |
CASI CASI Pharmaceuticals | $1.89
-2.7% | 4/9/2025 | Target Lowered by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $6.00 -> $4.00 | High | View details for HC Wainwright rating of CASI Pharmaceuticals (NASDAQ:CASI) on 4/9/2025 |
RICK RCI Hospitality | $42.04
-0.7% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $98.00 -> $98.00 | High | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 4/9/2025 |
RLYB Rallybio | $0.29
| 4/9/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Neutral | | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 4/9/2025 |
RNAC Cartesian Therapeutics | $9.97
-4.3% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/9/2025 |
BNGO Bionano Genomics | $3.84
-0.3% | 4/9/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy | $10.00 | High | View details for HC Wainwright rating of Bionano Genomics (NASDAQ:BNGO) on 4/9/2025 |
GMAB Genmab A/S | $19.39
-0.2% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $50.00 -> $37.00 | High | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/9/2025 |
IONS Ionis Pharmaceuticals | $32.26
-1.5% | 4/7/2025 | Upgraded by | HC Wainwright | Analyst M. Kapoor | Strong-Buy | $45.00 | High | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/7/2025 |
HRMY Harmony Biosciences | $34.05
-0.1% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $70.00 -> $70.00 | Medium | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 4/8/2025 |
VYGR Voyager Therapeutics | $3.24
-5.5% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 4/8/2025 |
NYXH Nyxoah | $6.30
+1.6% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 4/8/2025 |
CLNN Clene | $2.63
+1.9% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | High | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 4/8/2025 |
BHST BioHarvest Sciences | $6.44
-0.5% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of BioHarvest Sciences (NASDAQ:BHST) on 4/8/2025 |
MVST Microvast | $2.21
+5.7% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Microvast (NASDAQ:MVST) on 4/8/2025 |
VRCA Verrica Pharmaceuticals | $0.44
+6.0% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst O. Livnat | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Verrica Pharmaceuticals (NASDAQ:VRCA) on 4/8/2025 |
Elon Warns “America Is Broke”. Trump’s Plan Inside. (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
PCRX Pacira BioSciences | $25.12
+0.8% | 4/8/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $48.00 -> $65.00 | High | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 4/8/2025 |
PRLD Prelude Therapeutics | $0.78
-4.5% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 4/8/2025 |
LEGN Legend Biotech | $31.58
-1.4% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/8/2025 |
LXEO Lexeo Therapeutics | $2.69
-10.3% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 4/8/2025 |
RYTM Rhythm Pharmaceuticals | $57.37
-5.5% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $70.00 -> $80.00 | High | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 4/8/2025 |
VNRX VolitionRx | $0.50
-3.4% | 4/8/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of VolitionRx (NYSE:VNRX) on 4/8/2025 |
OPK OPKO Health | $1.26
-0.4% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 4/7/2025 |
CRDL Cardiol Therapeutics | $1.15
+0.9% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/7/2025 |
ANRO Alto Neuroscience | $2.21
+0.9% | 4/7/2025 | Initiated by | HC Wainwright | Analyst Patrick Trucchio | Buy | $10.00 | High | View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 4/7/2025 |
FLD FTAC Emerald Acquisition | $3.99
-3.6% | 4/7/2025 | Initiated by | HC Wainwright | Analyst Kevin Dede | Buy | $7.00 | Medium | View details for HC Wainwright rating of FTAC Emerald Acquisition (NASDAQ:FLD) on 4/7/2025 |
ZURA Zura Bio | $1.21
-4.0% | 4/3/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | High | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 4/3/2025 |
AURA Aura Biosciences | $5.23
-9.8% | 3/25/2025 | Target Set by | HC Wainwright | Analyst Edward White | | $25.00 | Medium | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 3/25/2025 |
SGMO Sangamo Therapeutics | $0.70
-2.8% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 4/7/2025 |
ARVN Arvinas | $6.61
-2.9% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $81.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 4/7/2025 |
DGXX Digihost Technology | $1.50
+0.7% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGXX) on 4/7/2025 |
BEAM Beam Therapeutics | $17.42
+1.0% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 4/7/2025 |
AVXL Anavex Life Sciences | $8.25
-3.6% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | Medium | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 4/7/2025 |
BCAX Bicara Therapeutics | $12.90
-1.8% | 4/7/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $45.00 -> $44.00 | High | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 4/7/2025 |
KSCP Knightscope | $5.05
-4.2% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $16.00 -> $12.00 | High | View details for HC Wainwright rating of Knightscope (NASDAQ:KSCP) on 4/7/2025 |
ANGO AngioDynamics | $9.11
-1.8% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $16.00 | Medium | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 4/7/2025 |
IONS Ionis Pharmaceuticals | $32.26
-1.5% | 4/7/2025 | Initiated by | HC Wainwright | Analyst Mitchell Kapoor | Buy | $45.00 | Medium | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/7/2025 |
SRTS Sensus Healthcare | $4.49
+0.4% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Sensus Healthcare (NASDAQ:SRTS) on 4/4/2025 |
ANY Sphere 3D | $0.63
-4.1% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 4/4/2025 |
ALDX Aldeyra Therapeutics | $2.18
+0.9% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/4/2025 |
RNXT RenovoRx | $1.06
+1.9% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of RenovoRx (NASDAQ:RNXT) on 4/4/2025 |
CYTK Cytokinetics | $31.69
-2.4% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | High | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 4/4/2025 |
CMPX Compass Therapeutics | $1.82
+2.2% | 4/4/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $10.00 -> $24.00 | Medium | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/4/2025 |
PHGE BiomX | $0.57
-23.0% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 4/4/2025 |
AKBA Akebia Therapeutics | $2.55
-2.7% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 4/4/2025 |
VANI Vivani Medical | $1.04
+1.5% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 4/4/2025 |
KALA KALA BIO | $3.42
-0.3% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 4/4/2025 |
OBIO Orchestra BioMed | $2.65
-7.7% | 4/4/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $12.00 | High | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 4/4/2025 |
IMAB I-Mab | $0.88
| 4/4/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $8.00 -> $7.00 | High | View details for HC Wainwright rating of I-Mab (NASDAQ:IMAB) on 4/4/2025 |
ALT Altimmune | $5.59
-3.6% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 4/3/2025 |
ARQT Arcutis Biotherapeutics | $13.53
+0.1% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for HC Wainwright rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
DAWN Day One Biopharmaceuticals | $6.45
-4.6% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $36.00 -> $36.00 | Low | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/3/2025 |
CTSO Cytosorbents | $0.87
+0.1% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Neutral -> Neutral | $1.00 -> $1.00 | Low | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 4/3/2025 |
ADAG Adagene | $1.60
| 4/3/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 4/3/2025 |
RANI Rani Therapeutics | $0.73
-5.9% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 4/3/2025 |
IPSC Century Therapeutics | $0.54
+3.3% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $2.00 | Medium | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 4/3/2025 |
ZURA Zura Bio | $1.21
-4.0% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 4/3/2025 |
MGX Metagenomi | $1.52
-4.7% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $14.00 -> $7.00 | High | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 4/3/2025 |
KYTX Kyverna Therapeutics | $2.11
-0.9% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $6.00 -> $4.00 | Low | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 4/3/2025 |
AXSM Axsome Therapeutics | $107.76
-1.0% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $200.00 -> $200.00 | High | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/3/2025 |
ACIU AC Immune | $1.67
+0.6% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 4/3/2025 |
HURA TuHURA Biosciences | $3.97
+1.0% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $13.00 -> $12.00 | Low | View details for HC Wainwright rating of TuHURA Biosciences (NASDAQ:HURA) on 4/3/2025 |
ALNY Alnylam Pharmaceuticals | $252.00
-2.5% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $500.00 -> $500.00 | Medium | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 4/2/2025 |
NRIX Nurix Therapeutics | $9.50
-1.5% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 4/2/2025 |
MIGI Mawson Infrastructure Group | $0.60
-1.6% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | Low | View details for HC Wainwright rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/2/2025 |
MDAI Spectral AI | $1.24
+5.1% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $3.50 -> $3.50 | Medium | View details for HC Wainwright rating of Spectral AI (NASDAQ:MDAI) on 4/2/2025 |
SRPT Sarepta Therapeutics | $36.27
-0.7% | 4/2/2025 | Upgraded by | HC Wainwright | Analyst M. Kapoor | Sell -> Neutral | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/2/2025 |
SRZN Surrozen | $8.35
-3.9% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $32.00 -> $32.00 | High | View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 4/2/2025 |
MLYS Mineralys Therapeutics | $14.65
-6.1% | 4/2/2025 | Target Raised by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $42.00 | Low | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 4/2/2025 |
AQST Aquestive Therapeutics | $2.79
+1.1% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/2/2025 |
GALT Galectin Therapeutics | $1.38
-1.4% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/2/2025 |
CABA Cabaletta Bio | $1.18
-2.5% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 4/1/2025 |
DARE Daré Bioscience | $2.91
-0.3% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 4/1/2025 |
UNCY Unicycive Therapeutics | $0.55
-11.6% | 4/1/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $4.00 -> $7.50 | High | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/1/2025 |
LGO Largo | $1.49
+3.5% | 4/1/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.70 -> $3.90 | Medium | View details for HC Wainwright rating of Largo (NYSE:LGO) on 4/1/2025 |
NMG Nouveau Monde Graphite | $1.81
-0.3% | 4/1/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.00 -> $2.75 | Low | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 4/1/2025 |
